Lupus autoantibody may help ‘awaken the silenced immune system’ to treat ‘cold’ cancers
An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor therapies used to treat cancers, according to recent findings.“Our findings are raising the possibility that autoantibodies reactive to nucleic acids in lupus play a more active role in promoting immune signaling than previously known,” James Hansen, MD,